Vir Biotechnology Appoints Suzanne Topalian to Board of Directors

• Vir Biotechnology appointed Suzanne Topalian to its board of directors, effective October 27, 2026.
• Topalian is a cancer immunotherapy professor at Johns Hopkins University School of Medicine, with research focused on anti-tumor immunity and PD-1 blockade.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261028809724) on October 28, 2026, and is solely responsible for the information contained therein.